Cefsulodin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Cefsulodin
Cefsulodin.png
Clinical data
AHFS/Drugs.com International Drug Names
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
ECHA InfoCard 100.052.431
Chemical and physical data
Formula C22H21N4O8S2+
Molar mass 533.556 g/mol
3D model (JSmol)
 NYesY (what is this?)  (verify)

Cefsulodin is a third-generation cephalosporin antibiotic that is active against Pseudomonas aeruginosa and was discovered by Takeda Pharmaceutical Company in 1977.[1]

TAP Pharmaceuticals had a new drug application on file with FDA for cefsulodin under the brand name Cefonomil as of 1985.[2]

Cefuslodin is most commonly used in cefsulodin-irgasan-novobiocin agar to select for Yersinia microorganisms.[3] This agar is most often used in water and beverage testing.

Susceptibility data[edit]

The following represents MIC susceptibility data for various P. aeruginosa strains:[4]

  • Pseudomonas aeruginosa PA13 (resistant strain): 32 μg/ml
  • Pseudomonas aeruginosa (wild-type, susceptible): 4 - 8 μg/ml

References[edit]